Bringing knowledge to life

iQur is at the forefront of vaccine research and development and molecular diagnostics

FIND OUT MORE

Bringing knowledge to life

iQur is at the forefront of vaccine research and development and molecular diagnostics

FIND OUT MORE
09 Apr, 2018
According to a recent issue of Vaccine (1), a team of UK based researchers have genetically modified the Hepatitis B virus shell to contain inserts from influenza virus. The resulting "virus-like particle" is not a live virus, but a completely safe and inert product which can be used as a new universal vaccine against influenza infection.
29 Jun, 2017
Unreliable yearly flu jabs could be a thing of the past as researchers close in on technology that will take down the deadly virus once and for all.
06 Aug, 2013
iQur announced that it has been granted €5 million ($6.6 million) by the European Union Framework 7 fund.

Get in touch today to see how we could help you with your next project!

CONTACT US
Share by: